World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
24622
World Ranking
12363
National Ranking
6330

Overview

Bernard Scatton is affiliated with the Club for Internet and Society Enthusiasts in the United States. Their research has primarily focused on biochemistry, genetics, molecular biology, and neuroscience, with particular work in molecular biology and cellular and molecular neuroscience.

Their main fields of study encompass:

  • Biochemistry, Genetics and Molecular Biology
  • Neuroscience

Subfields of particular emphasis include:

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Pharmacology

The topics frequently addressed in Scatton's research involve receptor mechanisms and signaling, neurotransmitter receptor influence on behavior, pharmacological receptor mechanisms and effects, nicotinic acetylcholine receptors study, cholinesterase and neurodegenerative diseases, and nerve injury and regeneration.

Main topics researched:

  • Receptor Mechanisms and Signaling
  • Neurotransmitter Receptor Influence on Behavior
  • Pharmacological Receptor Mechanisms and Effects
  • Nicotinic Acetylcholine Receptors Study
  • Cholinesterase and Neurodegenerative Diseases
  • Nerve injury and regeneration

Bernard Scatton has coauthored multiple papers with several frequently collaborating researchers including:

  • Jean-Martin Beaulieu
  • Emiliana Borrelli
  • Arvid Carlsson
  • Marc G. Caron
  • Olivier Civelli

Publication venues where Scatton's work has appeared include:

  • IUPHAR/BPS Guide to Pharmacology CITE
  • Journal of Neurochemistry

Their recent papers include:

  • Dopamine receptors in GtoPdb v.2023.1, 2023, IUPHAR/BPS Guide to Pharmacology CITE
  • An Obituary to Jacques Glowinski (1936-2020), 2021, Journal of Neurochemistry
  • Dopamine receptors in GtoPdb v.2025.3, 2025, IUPHAR/BPS Guide to Pharmacology CITE

Best Publications

  • Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

    Bernard Scatton;Liliane Rouquier;Bruno Dubois

  • Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

    Guy Griebel;Jacques Simiand;Claudine Serradeil-Le Gal;Jean Wagnon

  • Dopaminergic A10 neurones are involved in cognitive functions

    Hervé Simon;Bernard Scatton;Michel Le Moal

  • Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D2/D3 Receptor Antagonist with Both Presynaptic and Limbic Selectivity

    H. Schoemaker;Y. Claustre;D. Fage;L. Rouquier

  • Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat

    J.P. Herman;D. Guillonneau;R. Dantzer;B. Scatton

  • Origin of dopaminergic innervation of the rat hippocampal formation.

    Bernard Scatton;Herve Simon;Michel Le Moal;Serge Bischoff

  • Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.

    Magali Gary-Bobo;Ghizlane Elachouri;Jean François Gallas;Philip Janiak

  • Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.

    Marc Savasta;Alain Dubois;Bernard Scatton

  • 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-((1S)-2-cyclopropyl- 1-(3-fluoro-4-methylphenyl)ethyl)5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor 1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders

    Guy Griebel;Jacques Simiand;Régis Steinberg;Mireille Jung

  • Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.

    A. Dubois;M. Savasta;O. Curet;B. Scatton

  • Characterization of (2S,4R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist

    Claudine Serradeil-Le Gal;Jean Wagnon;Jacques Simiand;Guy Griebel

  • [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.

    B Bokobza;M Ruberg;B Scatton;F Javoy-Agid

  • Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.

    B Gotti;D Duverger;J Bertin;C Carter

  • Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity

    Gh. Perrault;R. Depoortere;E. Morel;D. J. Sanger

  • SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.

    Philippe Pichat;Olivier E Bergis;Jean-Paul Terranova;Alexandre Urani

  • Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

    Bernard Scatton

  • Dopaminergic and cholinergic lesions in progressive supranuclear palsy

    M Ruberg;F Javoy-Agid;E Hirsch;B Scatton

  • Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.

    Guy Griebel;Jeanne Stemmelin;Bernard Scatton

  • Antidopaminergic properties of yohimbine.

    B Scatton;B Zivkovic;J Dedek

  • Parkinson's disease and dementia: Norepinephrine and dopamine in locus ceruleus

    R. Cash;T. Dennis;R. L'Heureux;R. Raisman

Frequent Co-Authors

Guy Griebel
Guy Griebel Sanofi (France)
David I. Graham
David I. Graham University of Glasgow
Philippe Soubrié
Philippe Soubrié Collège de France
Salomon Z. Langer
Salomon Z. Langer National Scientific and Technical Research Council
F. Javoy-Agid
F. Javoy-Agid Pitie-Salpetriére Hospital
Jakob Korf
Jakob Korf University of Groningen
Marc Savasta
Marc Savasta Grenoble Alpes University
Gérard Le Fur
Gérard Le Fur Sanofi (France)
Yves Agid
Yves Agid Institut du Cerveau

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical degree in the USA isn't the only pathway to a rewarding healthcare career. Many students explore alternative or complementary online degrees to expand their options and enter the job market sooner. For instance, those seeking a faster route to patient care might consider the easiest nursing schools to get into, which often feature more flexible admissions policies.

If you’re interested in healthcare but not direct patient care, enrolling in a medical billing and coding schools with financial aid program can be a practical step toward a stable, in-demand position. For those who wish to bypass standardized entrance exams, there are also nursing school no entrance exam options available, making nursing more accessible than ever.

Additionally, an online degree in healthcare administration prepares graduates to take on leadership roles behind the scenes in hospitals and clinics. Exploring these online programs can help you find a career path that fits your personal goals and timeline.

Best Scientists Citing Bernard Scatton

Trending Scientists

Recently Published Articles